米多君
直立生命体征
氟屈可的松
医学
仰卧位
血压
麻醉
坐
重症监护医学
内科学
病理
氢化可的松
作者
Emmanuelle Vidal‐Petiot,Atul Pathak,J.-P. Azulay,Anne Pavy‐Le Traon,Olivier Hanon
标识
DOI:10.1016/j.neurol.2023.11.001
摘要
Orthostatic hypotension is defined as a drop in systolic blood pressure of at least 20 mmHg or a drop in diastolic blood pressure of at least 10 mmHg within 3 minutes of standing. It is a common disorder, especially in high-risk populations such as elderly subjects and patients with neurological diseases, and is associated with markedly increased morbidity and mortality. Its management can be challenging, particularly in cases where supine hypertension is associated with severe orthostatic hypotension. Education of the patient, non-pharmacological measures, and drug adaptation are the cornerstones of treatment. Pharmacological treatment should be individualized according to the severity, underlying cause, 24-hour blood pressure profile, and associated coexisting conditions. First-line therapies are midodrine and fludrocortisone, which may need to be combined for optimal care of severe cases.
科研通智能强力驱动
Strongly Powered by AbleSci AI